News
Biotech cools off in August as capital markets weaken September 01, 2010 | Press Release
Biotech gets hot in July August 02, 2010 | Press Release
Shawn Cross appointed CEO of Burrill Merchant Banking Group July 28, 2010 | Press Release
See all NewsPaul Berg—Cahill Professor in Biochemistry, Emeritus, Stanford University; Director, Emeritus, Beckman Center for Molecular and Genetic Medicine at Stanford; Nobel Laureate in Chemistry
Carl Feldbaum—President Emeritus, Biotechnology Industry Organization.
Frederick Frank—Vice Chairman and Director, Lehman Brothers.
Martin Gerstel—Chairman of Compugen, Keddem Bioscience and Evogene; Co-Chairman of Itamar Medical; former Co-Chairman and CEO of ALZA Corporation
Lee Hood—President of The Institute for Systems Biology
David M. Lawrence—Chairman and CEO (retired), Kaiser Foundation Health Plan and Hospitals
George Poste—CEO, Health Technology Networks; Director, The Biodesign Institute, Arizona State University; former CSTO and head of R&D, SmithKline Beecham
Tommy Thompson—Former Secretary of Health & Human Services; former Governor of Wisconsin; BLSCF II Advisory Board
